EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Six Dehydrogenase Gatekeepers of Carbohydrate Metabolism: Metabolic Integration in Health and Disease

Christos Papaneophytou, Christos Petrou

Frontiers in Bioscience-Landmark · 2026

DOI: 10.31083/fbl49369 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, 2026. Verfasst von Christos Papaneophytou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, School of Life and Health Sciences, University of Nicosia, 2417 Nicosia, Cyprus. Hauptthemen laut MEDLINE: Carbohydrate Metabolism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 302 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dehydrogenases function as metabolic gatekeepers, regulating carbon flux, redox balance, and biosynthetic capacity at critical branch points in cellular metabolism. This narrative review examines six key dehydrogenases, namely glyceraldehyde-3-phosphate dehydrogenase (GAPDH), lactate dehydrogenase (LDH), pyruvate dehydrogenase complex (PDHC), malate dehydrogenase (MDH1/2), isocitrate dehydrogenase (IDH1/2/3), and glucose-6-phosphate dehydrogenase (G6PDH), that collectively orchestrate the partitioning of nutrients among energy production, biosynthesis, and redox homeostasis. These enzymes share common features, including cofactor-dependent catalysis (NAD+/NADH or NADP+/NADPH), strategic positioning at metabolic nodes, and integration of compartmentalized metabolism between the cytosol and mitochondria. Under physiologic conditions, these dehydrogenases enable metabolic flexibility, allowing cells to adapt nutrient utilization to changing energetic demands and biosynthetic requirements. However, their dysregulation drives pathogenesis across diverse human diseases. In cancer, altered dehydrogenase activity supports metabolic reprogramming, exemplified by the Warburg effect mediated by LDHA, oncometabolite production (mutant IDH1/2), and enhanced biosynthetic capacity associated with G6PDH activity. Metabolic syndrome and diabetes feature PDHC suppression via pyruvate dehydrogenase kinase (PDK) upregulation, contributing to metabolic inflexibility and impaired glucose oxidation. Inherited enzymopathies, including G6PDH and PDHC deficiencies, underscore the essential roles of these enzymes and their tissue-specific requirements. In neurodegenerative disorders, oxidative modification of GAPDH promotes protein aggregation, whereas age-related decline in NAD+ compromises the activity of multiple NAD+-dependent dehydrogenases in a tissue- and context-dependent manner. The central importance of these enzymes has generated substantial therapeutic interest. Successful clinical translation includes mutant IDH inhibitors that reverse oncometabolite-driven epigenetic reprogramming in cancer. However, targeting essential metabolic enzymes presents challenges, including narrow therapeutic windows, metabolic compensation, and tissue-specific toxicities. Future therapeutic strategies will likely focus on exploiting disease-specific vulnerabilities, developing isoform-selective inhibitors, and combining metabolic interventions with conventional therapies. Understanding these six dehydrogenase gatekeepers provides crucial insights into metabolic regulation and highlights opportunities for precision-medicine approaches targeting the metabolic dependencies of human disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbohydrate MetabolismHumansAnimalsNeoplasmsIsocitrate DehydrogenaseMetabolic Reprogramming

Stichwörter der Autor:innen

dehydrogenasesglucose-6-phosphate dehydrogenaseglyceraldehyde-3-phosphate dehydrogenaseisocitrate dehydrogenaselactate dehydrogenasemalate dehydrogenaseoxidoreductasespyruvate dehydrogenase complex

Substanzen

Isocitrate Dehydrogenase

Autor:innen und Institutionen

  • Department of Life Sciences, School of Life and Health Sciences, University of Nicosia, 2417 Nicosia, Cyprus.
  • Department of Health Sciences, School of Life and Health Sciences, University of Nicosia, 2417 Nicosia, Cyprus.

Zitieren

APA

Papaneophytou, C., & Petrou, C. (2026). Six Dehydrogenase Gatekeepers of Carbohydrate Metabolism: Metabolic Integration in Health and Disease. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl49369

Vancouver

Papaneophytou C, Petrou C. Six Dehydrogenase Gatekeepers of Carbohydrate Metabolism: Metabolic Integration in Health and Disease. Frontiers in Bioscience-Landmark. 2026. doi:10.31083/fbl49369

BibTeX
@article{Papaneophytou2026,
  author = {Papaneophytou, Christos and Petrou, Christos},
  title = {Six Dehydrogenase Gatekeepers of Carbohydrate Metabolism: Metabolic Integration in Health and Disease},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  doi = {10.31083/fbl49369}
}
Kostenlos starten →